C4B and cancer: Over 20% of patients with colon cancer in the publicly available Memorial Sloan Kettering Cancer Center (MSKCC) clinical sequencing database have detectable CH (Cerami et al., 2012; Gao et al., 2013), which is notably more prevalent than in age-matched cancer-free population.